https://www.tandfonline.com/doi/abs/10.1080/09273948.2020.1820530?journalCode=ioii20
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Thursday, October 8, 2020
Does Pharmaceutical Compounding of Vascular Endothelial Growth Factor Inhibitors for Intravitreal Use Alter the Risk of Post-injection Endophthalmitis? Kathrine Blom , MDORCID Icon,Ragnheiður Bragadóttir , MD, PhD,Magne Sand Sivertsen , MD, PhD,Morten Carstens Moe , MD, PhD &Ystein Kalsnes Jørstad , MD, PhDORCID Icon Received 29 Apr 2020, Accepted 03 Sep 2020, Published online: 07 Oct 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment